Cindy CollingCarol FyeMike SatherControlled Clinical TrialsAustralian Government. (2016). School to Work Transitions research, reporting and evaluation. Retrieved from https://education.gov.au/school-work-transitions-research-reporting-and- evaluation...
Incomplete and inconsistent reporting of adverse events (AEs) through multiple sources can distort impressions of the overall safety of the medical interventions examined as well as the benefit-risk relationship. We aimed to assess completed allergic rhinitis (AR) trials registered in ClinicalTrials.gov...
Monitoring adverse social and medical events in public health trials: assessing predictors and interpretation against a proposed model of adverse event reporting... G Moody,K Addison,R Cannings-John,... - 《Current Controlled Trials in Cardiovascular Medicine》 被引量: 0发表: 2019年 Parents' Eval...
Clinical trials for medical device (MD) approval provide limited evidence before marketing, while post-market surveillance provides additional evidence on the effectiveness and safety [1, 2]. The reporting of adverse events in MDs is a starting point of post-market surveillance [3] and the most ...
Reporting bias represents a major problem in the assessment of health care interventions. Several prominent cases have been described in the literature, for example, in the reporting of trials of antidepressants, Class I anti-arrhythmic drugs, and select
Ioannidis JPMulrow CDGoodman SN Adverse events: the more you search, the more you find. Ann Intern Med 2006;144 (4) 298- 300PubMedGoogle ScholarCrossref 18. Jonville-Béra APGiraudeau BAutret-Leca E Reporting of drug tolerance in randomized clinical trials: when data conflict with authors'...
The change in clinical symptoms (e.g. reduction in volume of diarrhea) is used as the primary endpoint in most trials of acute GVHD treatment, but more accurate metrics are needed to predict long-term survival. Over the past decade, the Mount Sinai Acute GVHD International Consortium (MAGIC)...
Reporting bias represents a major problem in the assessment of health care interventions. Several prominent cases have been described in the literature, for example, in the reporting of trials of antidepressants, Class I anti-arrhythmic drugs, and select
摘要: To analyze the definition and causes of medical devices adverse events(MDAE), to discuss the factors,scope and principles of reporting MDAE. The importance of medical device adverse event monitoring is emphasized in this paper.关键词:...
(ARCOS) database,2a comprehensive data collection system of pharmacies and hospitals distribution of Schedule II and III controlled substances in the US with the FDA Adverse Event Reporting System (FAERS)3has never been done before. This approach may provide a more complete picture of the risks ...